Harvard Apparatus Regenerative Technology, Inc. (HRGN) Operating cash flow 2016–2025
Harvard Apparatus Regenerative Technology, Inc. (HRGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.8MFY2025 · since FY2016: -$9.1M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.8M | +21.1% |
| FY2024 | -$4.9M | +30.1% |
| FY2023 | -$6.9M | -35.9% |
| FY2022 | -$5.1M | -94.3% |
| FY2021 | -$2.6M | +35.0% |
| FY2020 | -$4.0M | +33.3% |
| FY2019 | -$6.1M | +20.7% |
| FY2018 | -$7.6M | +30.7% |
| FY2017 | -$11.0M | -21.6% |
| FY2016 | -$9.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HRGN financial trends
HRGN RevenueHRGN Net incomeHRGN Net marginHRGN Gross profitHRGN Gross marginHRGN Operating incomeHRGN Operating marginHRGN Free cash flowHRGN Capital expendituresHRGN Return on equityHRGN Stock buybacksHRGN Dividends paidHRGN Total assetsHRGN Total liabilitiesHRGN Shareholders’ equityHRGN overview →